US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 6.160
  • -0.020-0.32%
Close Jan 17 16:00 ET
  • 6.160
  • 0.0000.00%
Post 16:02 ET
275.90MMarket Cap-11.41P/E (TTM)

Y-mAbs Therapeutics Key Stats

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 24.373M--
--2024/Q4-- / 26.944M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--
May 7, 20242024/Q119.931M / 22.220M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 24.373M--
--2024/Q4-- / 26.944M--
Nov 8, 20242024/Q318.461M / 23.263M--
Aug 12, 20242024/Q222.798M / 23.019M--
May 7, 20242024/Q119.931M / 22.220M--

Unlock Free Earnings Estimates

Y-mAbs Therapeutics Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Jan 20, 2025

Buy

  • Buy

    75.00%
  • Hold

    12.50%
  • Sell

    12.50%

Price Target

No Data